Pareja Eugenia, Cortés Miriam, Martínez Amparo, Vila Juan José, López Rafael, Montalvá Eva, Calzado Angeles, Mir José
Unidad de Cirugía y Trasplante Hepático, Hospital Universitario La Fe, Valencia, España.
Cir Esp. 2010 Jul;88(1):3-11. doi: 10.1016/j.ciresp.2010.03.013. Epub 2010 May 26.
Liver transplantation has been remarkably effective in the treatment in patients with end-stage liver disease. However, disparity between solid-organ supply and increased demand is the greatest limitation, resulting in longer waiting times and increase in mortality of transplant recipients. This situation creates the need to seek alternatives to orthotopic liver transplantation.Hepatocyte transplantation or liver cell transplantation has been proposed as the best method to support patients. The procedure consists of transplanting individual cells to a recipient organ in sufficient quantity to survive and restore the function. The capacity of hepatic regeneration is the biological basis of hepatocyte transplantation. This therapeutic option is an experimental procedure in some patients with inborn errors of metabolism, fulminant hepatic failure and acute and chronic liver failure, as a bridge to orthotopic liver transplantation. In the Hospital La Fe of Valencia, we performed the first hepatocyte transplantation in Spain creating a new research work on transplant program.
肝移植在终末期肝病患者的治疗中已取得显著成效。然而,实体器官供应与需求增加之间的差距是最大的限制因素,导致等待时间延长和移植受者死亡率上升。这种情况促使人们寻求原位肝移植的替代方案。肝细胞移植已被提议作为支持患者的最佳方法。该手术包括将足够数量的单个细胞移植到受体器官中,使其存活并恢复功能。肝脏再生能力是肝细胞移植的生物学基础。对于一些患有先天性代谢缺陷、暴发性肝衰竭以及急慢性肝衰竭的患者,这种治疗选择作为原位肝移植的桥梁,是一种实验性手术。在巴伦西亚的拉斐医院,我们在西班牙进行了首例肝细胞移植,开创了一项关于移植项目的新研究工作。